Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial - Paterson, Alexander HG; Anderson, Stewart J; Lembersky, Barry C; Fehrenbacher, Louis; Falkson, Carla I; King, Karen M; Weir, Lorna M; Brufsky, Adam M; Dakhil, Shaker; Lad, Thomas; Baez-Diaz, Luis; Gralow, Julie R; et al. (The lancet oncology, 2012)
Keywords: Administration, Oral; Adult; Age Factors; Aged; Bisphosphonates; Bone Density Conservation Agents - therapeutic use; Breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - mortality; Cancer therapies; Chemotherapy; Clinical trials; Clodronic Acid - adverse effects; Clodronic Acid - therapeutic use; Disease-Free Survival; Double-Blind Method; Endocrine therapy; Female; Hematology, Oncology and Palliative Medicine; Humans; Metastasis; Middle Aged; Patients; Womens health; North America